Abingworth is a venture capital firm founded in 1973. The firm's headquarters is located in London, United Kingdom, with additional offices in the United States at San Francisco and Boston. As of October 2019, Abingworth has sold off its ownership in 134 companies and is currently managing a portfolio of 25 companies.
Abingworth focuses on funding companies based in Europe and the United States. Sector-wise, Abingworth provides funding for companies in the life sciences industry, with a specific interest in fields such as biotherapeutics, small molecules, nucleic acid therapeutics, and vaccines. For each company, the firm allocates an investment total at a range of $15-$30 million.
A biopharmaceutical company focusing on the discovery, development, and commercialization of RNAi therapeutics for treating rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases.
A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K.
Labcyte is a global biotechnology tools company headquartered in San Jose, California, that develops tools for liquid handling.
A company focused on development of products to treat central nervous system disorders, pain and rare diseases
A company developing therapies for psychological and neurological illnesses
Scorpion Therapeutics is a Boston-based company founded in 2020.
Chiasma Pharma is a Waltham, Massachusetts-based biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
Avedro is a company that is advancing the field of Corneal Remodeling.
VirionHealth is a biotechnology company
Personalis is a Menlo Park, California-based biotechnology company working to commercialize cancer immunotherapies founded in 2011.
Dicerna Pharmaceuticals is a company that focuses on the discovery and development of treatments for inherited diseases.
Pathwork Diagnostics is a Redwood City, California-based molecular diagnostics for oncology company founded by Glenda G. Anderson.
GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
PrimeraDx is a molecular diagnostics company that develops and commercializes a clinical platform
Clovis Oncology is a Boulder, Colorado-based biopharmaceutical company developing and commercializing cancer treatments.
TruCode Gene Repair is a South San Francisco, California-based company founded by Marshall Fordyce.
VenatorRx Pharmaceuticals is a Malvern, Pennsylvania-based biotechnology and pharmaceutical company working in the discovery and development of anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
A company developing RNA-based therapeutics for genetic disorders, infections and cancer
Epigenomics AG is a Berlin-based molecular diagnostics company focused on the development of diagnostic tests for cancer.
Gynesonics develops an ablatian device for uterine fibroids.
A company dedicated on the discovery and development of small molecule therapeutics to treat cancer
A biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions
Partner, Portfolio Manager
Partner and CFO
Partner and General Counsel
Kurt von Emster
Partner, Marketing and Talent
Chairman & Managing Partner